BAKER BROS. ADVISORS LP Q1 2016 Filing
Filed May 16, 2016
Portfolio Value
$9.5B
Holdings
134
Report Date
Q1 2016
Filing Type
13F-HR
All Holdings (134 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | —Immune Design Corp. | 148,937 | $1.9B | 20.42% | |
| 102 | KPTIEURKaryopharm Therapeutics Inc. | 216,990 | $1.9B | 20.42% | |
| 103 | IRWDIronwood Pharmaceuticals, Inc. | 169,163 | $1.9B | 19.52% | |
| 104 | —MediWound Ltd. | 226,000 | $1.8B | 19.24% | |
| 105 | —CytRx Corporation | 659,995 | $1.8B | 18.66% | |
| 106 | —Stemline Therapeutics, Inc. | 333,497 | $1.6B | 16.39% | |
| 107 | —Ophthotech Corporation | 35,649 | $1.5B | 15.89% | |
| 108 | —Affimed N.V. | 400,000 | $1.5B | 15.78% | |
| 109 | DVAXDynavax Technologies Corporation | 75,000 | $1.4B | 15.22% | |
| 110 | CLLSCellectis S.A. | 50,000 | $1.4B | 14.50% | |
| 111 | —ProNai Therapeutics, Inc. | 200,000 | $1.3B | 14.22% | |
| 112 | —Mast Therapeutics, Inc. | 4,797,442 | $1.3B | 13.80% | |
| 113 | ASMBAssembly Biosciences, Inc. | 250,000 | $1.3B | 13.24% | |
| 114 | AMRNAmarin Corporation plc | 801,860 | $1.2B | 12.94% | |
| 115 | —Palatin Technologies, Inc. | 2,050,000 | $1.1B | 11.67% | |
| 116 | —GW Pharmaceuticals plc | 15,000 | $1.1B | 11.41% | |
| 117 | —Tenax Therapeutics, Inc. | 420,000 | $861.0M | 9.08% | |
| 118 | ADAPYAdaptimmune Therapeutics plc | 100,000 | $813.0M | 8.57% | |
| 119 | —Five Prime Therapeutics, Inc. | 19,247 | $782.0M | 8.25% | |
| 120 | XLRNAcceleron Pharma, Inc. | 28,765 | $759.0M | 8.00% | |
| 121 | I9DNArbutus Biopharma Corporation | 180,582 | $746.0M | 7.87% | |
| 122 | ALNYAlnylam Pharmaceuticals, Inc. | 11,340 | $712.0M | 7.51% | |
| 123 | —BioDelivery Sciences International, Inc. | 210,021 | $678.0M | 7.15% | |
| 124 | ALDXAldeyra Therapeutics, Inc. | 142,000 | $595.0M | 6.27% | |
| 125 | CMRXEURChimerix, Inc. | 115,216 | $589.0M | 6.21% | |
| 126 | —Ritter Pharmaceuticals, Inc. | 400,000 | $452.0M | 4.77% | |
| 127 | —Discovery Laboratories, Inc. | 254,973 | $426.0M | 4.49% | |
| 128 | —Foundation Medicine, Inc. | 20,892 | $380.0M | 4.01% | |
| 129 | —La Jolla Pharmaceutical Company | 13,746 | $287.0M | 3.03% | |
| 130 | —Achaogen, Inc. | 100,000 | $276.0M | 2.91% | |
| 131 | CCXIEURChemoCentryx, Inc. | 49,064 | $122.0M | 1.29% | |
| 132 | —Aptose Biosciences Inc. | 33,397 | $100.0M | 1.05% | |
| 133 | BGMS 6 PERPCyclacel Pharmaceuticals, Inc. | 13,253 | $76.0M | 0.80% | |
| 134 | —BioTime, Inc. | 20,084 | $12.0M | 0.13% |
PreviousPage 2 of 2